Search

Your search keyword '"Integrins drug effects"' showing total 228 results

Search Constraints

Start Over You searched for: Descriptor "Integrins drug effects" Remove constraint Descriptor: "Integrins drug effects"
228 results on '"Integrins drug effects"'

Search Results

2. Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo .

Catalog

Books, media, physical & digital resources

3. The Antithrombotic Agent Pterostilbene Interferes with Integrin α IIb β 3 -Mediated Inside-Out and Outside-In Signals in Human Platelets.

4. An in Vitro Assay to Study the Role of Opioids in Modulating Immune Cell Adhesion.

5. c(RGDfK)- and ZnTriMPyP-Bound Polymeric Nanocarriers for Tumor-Targeted Photodynamic Therapy.

6. Integrin Antibody Decreases Deformability of Patient-Derived Pre-B Acute Lymphocytic Leukemia Cells as Measured by High-Frequency Acoustic Tweezers.

7. Integrins as A New Target for Cancer Treatment.

8. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.

9. D-mannose induces regulatory T cells and suppresses immunopathology.

10. Cadmium stimulates metastasis-associated phenotype in triple-negative breast cancer cells through integrin and β-catenin signaling.

11. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

12. Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.

13. Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.

14. Recombinant Osteopontin Stabilizes Smooth Muscle Cell Phenotype via Integrin Receptor/Integrin-Linked Kinase/Rac-1 Pathway After Subarachnoid Hemorrhage in Rats.

15. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.

16. Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.

17. Therapeutic targeting of integrin αvβ6 in breast cancer.

18. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.

20. Integrin modulators: a patent review.

21. Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.

22. Cigarette smoke extract induces select matrix metalloproteinases and integrin expression in periodontal ligament fibroblasts.

23. The influence of different implant materials on human gingival fibroblast morphology, proliferation, and gene expression.

24. Non-RGD-containing snake venom disintegrins, functional and structural relations.

25. Inhibitory effects of novel integrin-targeting peptides on angiogenesis activity in HUVEC cells in vitro.

26. Self-assembly of elastin-based peptides into the ECM: the importance of integrins and the elastin binding protein in elastic fiber assembly.

27. Bone morphogenetic protein-7 enhances cementoblast function in vitro.

28. Integrins as target: first phase III trial launches, but questions remain.

29. CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo.

30. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex.

31. Integrins in bone metastasis formation and potential therapeutic implications.

32. S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.

33. Conformational mAb as a tool for integrin ligand discovery.

34. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases.

35. In vivo positron emission tomography (PET) imaging with an alphavbeta6 specific peptide radiolabeled using 18F-"click" chemistry: evaluation and comparison with the corresponding 4-[18F]fluorobenzoyl- and 2-[18F]fluoropropionyl-peptides.

36. A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acids.

37. Integrins in angiogenesis and lymphangiogenesis.

38. Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.

39. Novel therapeutic targets at the platelet vascular interface.

40. Cyclophilin B induces integrin-mediated cell adhesion by a mechanism involving CD98-dependent activation of protein kinase C-delta and p44/42 mitogen-activated protein kinases.

41. Neural crest motility on fibronectin is regulated by integrin activation.

42. Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment.

43. Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP.

44. The lipoxygenase inhibitor, baicalein, modulates cell adhesion and migration by up-regulation of integrins and vinculin in rat heart endothelial cells.

45. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds.

46. Integrins: novel therapeutic targets for cardiovascular diseases.

47. Continuous requirement for pp60-Src and phospho-paxillin during fibronectin matrix assembly by transformed cells.

48. A protein kinase signal-responsive gene carrier modified RGD peptide.

49. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells.

50. Semaphorin 3C regulates endothelial cell function by increasing integrin activity.